Amili
Kimberly Foo has a variety of work experience in the scientific field. From 2020 to 2022, they worked at Intertek as a Laboratory Technician and later as a Quality Control Officer. In 2022, they joined Pharmaceutics MDPI as an Assistant Editor and then became a Section Managing Editor in early 2023. Currently, they hold the position of Laboratory and Research Executive at AMILI starting from April 2023.
Kimberly Foo completed a Master's degree in Biotechnology from The University of Western Australia, with an end year of 2020. Prior to that, from 2013 to 2016, they obtained a Bachelor's degree in Microbiology and Immunology, with a minor in Pharmacology, from the same institution.
This person is not in any offices
Amili
Asian Microbiome Library (AMILI) is Southeast Asia’s first precision gut microbiome company and only stool bank serving as a hub for gut microbiome innovation and therapy. Their aim is to advance microbiome research, grounded in science and compassion, to address unmet and critical needs in healthcare with the potential to positively impact millions of lives across Asia.